Zobrazeno 1 - 10
of 22
pro vyhledávání: '"Amanda K. Cartee"'
Publikováno v:
Gastro Hep Advances, Vol 3, Iss 1, Pp 4-6 (2024)
Externí odkaz:
https://doaj.org/article/eabb14ffe33d445886ea6e76279dc958
Autor:
David A. Katzka, Vandana Nehra, Amanda K. Cartee, Rok Seon Choung, Eric V. Marietta, Joseph A. Murray, Robert P. Anderson, Chadrick A. Hinson, Madhusudan Grover, Katherine S. King, John L. Dzuris, Suyue Wang, Carol T. Van Dyke
Publikováno v:
American Journal of Gastroenterology. 117:319-326
Introduction Treated patients with celiac disease (CeD) and nonceliac gluten sensitivity (NCGS) report acute, transient, incompletely understood symptoms after suspected gluten exposure. To determine whether (i) blinded gluten exposure induces sympto
Publikováno v:
Gastroenterology. 162:S-255
Autor:
Joseph A. Murray, Amanda K. Cartee
Publikováno v:
Medical Journal of Australia. 212:111-112
Autor:
Joseph J. Larson, Joseph A. Murray, S. Vincent Rajkumar, Alastair B. Ross, Katherine S. King, Rok Seon Choung, Eric V. Marietta, Shahryar Khaleghi, Alberto Rubio-Tapia, Michael J. Camilleri, Amanda K. Cartee, Otto Savolainen
Publikováno v:
Gastroenterology
Background & Aims Celiac disease can develop at any age, but outcomes of adults with positive results from serologic tests for tissue transglutaminase antibodies (tTGA) without endoscopic determination of celiac disease (called celiac autoimmunity) h
Autor:
Amanda K. Cartee, Joseph A. Murray
Publikováno v:
Essential Medical Disorders of the Stomach and Small Intestine ISBN: 9783030011161
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f1d26add687d606d8a62a3ccb1c27325
https://doi.org/10.1007/978-3-030-01117-8_17
https://doi.org/10.1007/978-3-030-01117-8_17
Autor:
Brian D. Lahr, Barbara P. Yawn, Joseph A. Murray, Yogish C. Kudva, Amanda K. Cartee, Lisa A. Owens
Publikováno v:
Mayo Clinic Proceedings. 91:1066-1073
Objectives To investigate the recent incidence of T1D in a US Midwestern county to determine whether this increase has been sustained and compare it with the incidence of celiac disease (CD) and also investigate the prevalence of CD, an associated au
Publikováno v:
Gastroenterology. 155(4)
Autor:
Tsung-Teh Wu, Amanda K. Cartee, Rok-Seon Choung, Alberto Rubio-Tapia, Ashley Nadeau, I. Singh, Abdul Rishi, Eric V. Marietta, Joseph A. Murray
Publikováno v:
Alimentary Pharmacology & Therapeutics. 42:1303-1314
Summary Background Olmesartan-associated enteropathy (OAE) is characterised by diarrhoea, nausea, vomiting, abdominal pain, weight loss and severe sprue-like enteropathy, all of which are resolved after discontinuation of olmesartan medoximil. Aim To
Publikováno v:
Digestive Diseases. 33:215-220
Background/Aims: Many medications can cause diarrhea by increasing motility, inflammation or enteropathy. Olmesartan and mycophenolic acid (CellCept) are drugs that are capable of increasing inflammation and enteropathy in some individuals and, if no